author-photo

Kevin Ramchandar

Northwestern University

4

Papers

32

Citations

Citation Trend

Filter By

Papers (3) Sort By

Journal Conference Others

Canadian Phase III Randomized Trial of Stereotactic Body Radiotherapy Versus Conventionally Hypofractionated Radiotherapy for Stage I, Medically Inoperable Non-Small-Cell Lung Cancer - Rationale and Protocol Design for the Ontario Clinical Oncology Group (OCOG)-LUSTRE Trial.

2017 Clinical Lung Cancer
Show All
- Source
- Cite
- Save
Citations (17)
A meta-analysis of trials of etoposide plus platinum agent versus irinotecan/topotecan plus platinum agent in first-line therapy of extensive stage small cell lung cancer (ES SCLC).

2017 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (0)
Quality of life (QOL) in a phase III randomized trial of standard fractionation radiotherapy (SFX) with concurrent cisplatin (CIS) versus accelerated fractionation radiotherapy (AFX) with panitumumab (PMab) in patients (pts) with locoregionally advanced squamous cell carcinoma of the head and neck (LA-SCCHN): NCIC Clinical Trials Group HN.6 (NCT00820248).

2015 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (3)